Skip to main content
. 2017 Jul 26;7:6595. doi: 10.1038/s41598-017-06632-y

Figure 3.

Figure 3

The results of the aligned TKIs. (A) Gefitinib. 2ITY was the template. (B) Erlotinib. 1M17 was the template. (C) Afatinib. 4G5J was the template. Each figure contained four TKIs. Three of them were for the EGFR mutant-TKI complexes and the other one was for the template.